Somxl Homeopathic Wart Remover
Thuja Occidentalis Leafy Twig
Wr Group Skin Care Ltd
Human Otc Drug
NDC 70463-725Somxl Homeopathic Wart Remover also known as Thuja Occidentalis Leafy Twig is a human otc drug labeled by 'Wr Group Skin Care Ltd'. National Drug Code (NDC) number for Somxl Homeopathic Wart Remover is 70463-725. This drug is available in dosage form of Cream. The names of the active, medicinal ingredients in Somxl Homeopathic Wart Remover drug includes Thuja Occidentalis Leafy Twig - 6 [hp_X]/15g . The currest status of Somxl Homeopathic Wart Remover drug is Active.
Drug Information:
| Drug NDC: | 70463-725 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Somxl Homeopathic Wart Remover |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Thuja Occidentalis Leafy Twig |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Wr Group Skin Care Ltd |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Cream |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | THUJA OCCIDENTALIS LEAFY TWIG - 6 [hp_X]/15g
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 05 Feb, 2016 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 24 Dec, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | WR Group Skin Care Ltd
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | 1NT28V9397
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 70463-725-01 | 1 TUBE in 1 BOX (70463-725-01) / 15 g in 1 TUBE | 05 Feb, 2016 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose wart remover
Product Elements:
Somxl homeopathic wart remover thuja occidentalis leafy twig water c13-14 isoparaffin hydrogen peroxide laureth-7 sodium stannate thuja occidentalis leafy twig thuja occidentalis leafy twig
Indications and Usage:
Use for the removal of common warts. the common wart is easily recognized by the rough âcauliflower-likeâ appearance on the surface.
Warnings:
Warnings for external use only if product gets into eyes, flush with water for 15-minutes. avoid inhaling vapors. do not use ⢠on irritated skin ⢠on any area that is infected or reddened ⢠if you are diabetic or if you have poor blood circulation ⢠miles ⢠birthmarks ⢠warts with hair growing from them ⢠gential warts ⢠warts on the face or mucous membranes stop use and ask a doctor if discomfort persists if pregnant or breast-feeding, ask a health professional before use. keep out of reach of children. if swallowed, get medical help or contact a poison control center right away.
Do Not Use:
Warnings for external use only if product gets into eyes, flush with water for 15-minutes. avoid inhaling vapors. do not use ⢠on irritated skin ⢠on any area that is infected or reddened ⢠if you are diabetic or if you have poor blood circulation ⢠miles ⢠birthmarks ⢠warts with hair growing from them ⢠gential warts ⢠warts on the face or mucous membranes stop use and ask a doctor if discomfort persists if pregnant or breast-feeding, ask a health professional before use. keep out of reach of children. if swallowed, get medical help or contact a poison control center right away.
Dosage and Administration:
Directions â¢wash affected area (may soak wart in warm water for 15-minutes if desired). ⢠dry area throughly. ⢠apply small amount with applicator to cover each wart. let dry. ⢠repeat this procedure once or twice daily as needed for up to 12-weeks.
Stop Use:
Stop use and ask a doctor if discomfort persists
Package Label Principal Display Panel:
Package labeling: label